European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Predictive factors for lumacaftor/ivacaftor clinical response.

Predictive factors for lumacaftor/ivacaftor clinical response.

Resource Type

CF Research News

Authors

Masson A, Schneider-Futschik EK, Baatallah N, Nguyen-Khoa T, Girodon E, Hatton A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Kyrilli S, Achimastos D, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

References

J Cyst Fibros. 2019 May;18(3):368-374. doi: 10.1016/j.jcf.2018.12.011. Epub 2018 Dec 28.
 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Date

Saturday, May 18, 2019

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [3]
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/predictive-factors-lumacaftorivacaftor-clinical-response

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-48_R1_Sermet_FINAL_310819.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=PREDICTIVE%20FACTORS%20FOR%20LUMACAFTOR/IVACAFTOR%20CLINICAL%20RESPONSE [3] https://www.ecfs.eu/resource-guideline-type/other-guidelines